Unusual 11 Mid-Day Movers 12/01: BIOF, ZN, GSIT, CAGC, RDN Higher; STAA, LTON, ZOOM, OVTI Lower

December 1, 2009 2:12 PM EST

BioFuel Energy (Nasdaq: BIOF) 33.7% HIGHER; has jumped on headlines the EPA said it will decide on raising ethanol levels in gasoline in Mid-2010.

STAAR Surgical (Nasdaq: STAA) 23% LOWER; the stock is tumbling on heavy volume today as it could be breaking below some technical barriers. Shares haven't traded below the $3 level since early September.

Zion Oil & Gas (NYSE: ZN) 17.8% HIGHER; may be trading higher today as its rights offering to stockholders was significantly oversubscribed: preliminary results suggest subscriptions for over $37 million, which was much higher than the $18 million available.

Linktone (NASDAQ: LTON) 17.8% LOWER; reports Q3 adj-EPS of $0.01, compared to $0.02 in the same quarter last year. Revenue for the quarter was $17.6 million, versus $16.59 million in Q308.

GSI Technology Inc. (Nasdaq: GSIT) 17.3% HIGHER; continuing higher today. The stock surged nearly 40% yesterday amid news about the availability of SigmaQuad-IIIe and SigmaDDR-IIIe, two new SRAM products whose revolutionary architecture provides the ultimate in system performance, reliability, and flexibility for applications that require a high random address rate.

China Agritech (Nasdaq: CAGC) 17.2% HIGHER; not hearing any company-specific news but agriculture-related stocks may be rising today amid the ethanol news.

ZOOM Technologies (Nasdaq: ZOOM) 16.4% LOWER; not seeing any news that would justify today's decline.

Radian (NYSE: RDN) 14.3% HIGHER; shares are trading sharply higher today following some bullish comments from the company's CFO, Bob Quint, earlier. Among other comments, the exec said November delinquencies were less than expected. Click here to see some more highlights from the exec's presentation.

Euro Tech Holdings (Nasdaq: CLWT) 14% HIGHER; the stock is continuing higher today following yesterday's technical breakout. Volume remains very heavy.

Omnivision Technologies (NASDAQ: OVTI) 10.5% LOWER; reports Q2 EPS of $0.27, ex-items, 11 cents better than the analyst estimate of $0.16. Revenue for the quarter was $183.3 million, which compares to the estimate of $163.74 million. Sees Q3 sales of $145-$160 million and adj-EPS of $0.14-$0.24.

Protalix BioTherapeutics (NYSE: PLX) 10.2% LOWER; following a commercialization deal with Pfizer (NYSE: PFE) this morning, traders are saying that they are disappointed that there was no merger deal. Fast money was speculating that Protalix would be acquired by Teva (Nasdaq: TEVA) or Pfizer. With no merger, we are seeing a "sell the news" reaction.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Unusual 11 Mid-Day Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?